Control of cardiovascular risk factors in patients with type 2 diabetes and hypertension in a French national study (Phenomen)

This publication has 24 references indexed in Scilit:

• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  Published by Elsevier ,2002
• Effect of Pravastatin on Coronary Disease Events in Subgroups Defined by Coronary Risk Factors
  Circulation, 2000
• Reduced Coronary Events in Simvastatin-Treated Patients With Coronary Heart Disease and Diabetes or Impaired Fasting Glucose Levels
  Archives of internal medicine (1960), 1999
• Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39
  BMJ, 1998
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
  BMJ, 1998
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
  The Lancet, 1998
• Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS: 23)
  BMJ, 1998
• Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S)
  Diabetes Care, 1997
• Diabetes and hypertension
  Journal Of Hypertension, 1997
• A prospective study of mortality among middle-aged diabetic patients (the London cohort of the WHO Multinational Study of Vascular Disease in Diabetics) I: causes and death rates
  Diabetologia, 1990